- Home
- Publications
- Publication Search
- Publication Details
Title
PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
Authors
Keywords
Pediatric malignancies, Rhabdomyosarcoma, Soft tissue sarcoma, PD-L1 expression, Flow cytometry, Immunohistrochemistry, Primary cell lines
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-15
DOI
10.1186/s12885-018-4554-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
- (2018) Yan-bin Chen et al. TUMORI
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Cancer Immunotherapy Trials Not Immune from Imprecise Selection of Patients
- (2017) Edward B. Garon NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and PD-L1 expression in bone and soft tissue sarcomas
- (2017) Alireza Torabi et al. PATHOLOGY
- Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors
- (2017) Navin Pinto et al. PEDIATRIC BLOOD & CANCER
- Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
- (2016) Chan Kim et al. BMC CANCER
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members
- (2014) Francesca Megiorni et al. BMC CANCER
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
- (2014) Jason Madore et al. Pigment Cell & Melanoma Research
- Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
- (2013) Xiang Chen et al. CANCER CELL
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Selecting multimodal therapy for rhabdomyosarcoma
- (2010) Iyad Sultan et al. Expert Review of Anticancer Therapy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started